{"organizations": [], "uuid": "322a3c67f03db525d06ab0db6162bd5389aa78fb", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-mayne-pharmas-nda-for-suba-itracon/brief-mayne-pharmas-nda-for-suba-itraconazole-capsules-accepted-for-review-by-u-s-fda-idUSFWN1S80P1", "country": "US", "domain_rank": 408, "title": "BRIEF-Mayne Pharma's NDA For Suba-Itraconazole Capsules Accepted For Review By U.S. FDA", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-05-02T03:35:00.000+03:00", "replies_count": 0, "uuid": "322a3c67f03db525d06ab0db6162bd5389aa78fb"}, "author": "", "url": "https://www.reuters.com/article/brief-mayne-pharmas-nda-for-suba-itracon/brief-mayne-pharmas-nda-for-suba-itraconazole-capsules-accepted-for-review-by-u-s-fda-idUSFWN1S80P1", "ord_in_thread": 0, "title": "BRIEF-Mayne Pharma's NDA For Suba-Itraconazole Capsules Accepted For Review By U.S. FDA", "locations": [], "entities": {"persons": [{"name": "suba-itraconazole capsu", "sentiment": "negative"}], "locations": [{"name": "u.s.", "sentiment": "none"}], "organizations": [{"name": "brief-mayne pharma", "sentiment": "negative"}, {"name": "nda", "sentiment": "negative"}, {"name": "u.s. fda", "sentiment": "negative"}, {"name": "mayne pharma group ltd", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}, {"name": "u.s. fda reuters staff", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "May 2 (Reuters) - Mayne Pharma Group Ltd:\n* NEW DRUG APPLICATION FOR SUBA-ITRACONAZOLE CAPSULES ACCEPTED FOR REVIEW BY U.S. FOOD AND DRUG ADMINISTRATION Source text for Eikon: Further company coverage:\n ", "external_links": [], "published": "2018-05-02T03:35:00.000+03:00", "crawled": "2018-05-02T04:08:23.000+03:00", "highlightTitle": ""}